
08/04/2025
NCHR's Dr. Diana Zuckerman told the FDA that MDUFA V had more than 200 demands on . Who is regulating who? MDUFA VI should require device companies to provide funds for FDA staff who focus on thorough reviews that provide evidence of safety and effectiveness, patients' informed consent, and better post-market surveillance of ads and quality of devices. Read her comment here:
Diana Zuckerman of NCHR presented at FDA 1st public MDUFA VI meeting of 2025, about device performance goals that enhance safety, effectiveness, transparency